Abby Med Overview
- Year Founded
-
2013
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
Abby Med General Information
Description
Operator of a biotechnology company intended to develop a novel class of cancer drugs targeting malignant gliomas. The company engages in developing personalized cancer therapies to fight malignant gliomas using triphenylmethanes which are effective against human glioma cell lines, enabling physicians to offer effective chemotherapeutic treatments and improve survival outcomes.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 571 Pelham Road North East
- Atlanta, GA 30324
- United States
+1 (404) 000-0000
Abby Med Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Secondary Transaction - Private | 01-Nov-2022 | 000 | Completed | Startup | ||
| 2. Grant | 23-Oct-2014 | 00000 | 000 | Completed | Startup | |
| 1. Seed Round | 15-Jan-2014 | $1M | $1M | Completed | Startup |
Abby Med Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Jack Arbiser Ph.D | Co-Founder |
Abby Med Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Emory University Department of Human Genetics | Corporation | 000 0000 | 000000 0 |